Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Brentuximab Vedotin × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Mycosis Fungoides 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Melanoma 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 9 Vincristine 7 venetoclax 5 prednylidene 5 deltacortene 5 Prednisone 5 Doxorubicin 5 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Methotrexate 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Dexamethasone 4 Cytarabine 4 Calcium Dobesilate 4 pegaspargase 3 calaspargase pegol 3 Stem Cell Transplantation 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 nelarabine 2 mogamulizumab 2 fludarabine phosphate 2 fludarabine 2 exifone 2 azathiopurine 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡